Clinical Experience of Gefitinib in the Treatment of 32 Lung Adenocarcinoma Patients with Brain Metastases

Clinical Experience of Gefitinib in the Treatment of 32 Lung Adenocarcinoma Patients with Brain Metastases

Background and objective Brain metastasis was frequent in non-small cell lung cancer (NSCLC) patients with poor prognosis. Gefitinib was an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor which has been used in the treatment of NSCLC. Our study was to evaluate the efficacy and toxi...

Full description

Bibliographic Details
Main Authors: Jianping XU, Xiaoyan LIU, Sheng YANG, Xiangru ZHANG, Yuankai SHI
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-09-01
Series:Chinese Journal of Lung Cancer
Subjects:
Gefitinib
Lung neoplasms
Brain metastasis
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.09.05

Similar Items

Similar Items